252 related articles for article (PubMed ID: 20562426)
1. Early diagnosis of anthracycline toxicity in asymptomatic long-term survivors: dobutamine stress echocardiography and tissue Doppler velocities in normal and abnormal myocardial wall motion.
Yildirim A; Sedef Tunaoglu F; Pinarli FG; Ilhan M; Oguz A; Karadeniz C; Olguntürk R; Oguz D; Kula S
Eur J Echocardiogr; 2010 Dec; 11(10):814-22. PubMed ID: 20562426
[TBL] [Abstract][Full Text] [Related]
2. [The role of dobutamine stress echocardiography in early diagnosis of cardiac toxicity in long-term survivors of asymptomatic children treated with anthracycline].
Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
Anadolu Kardiyol Derg; 2010 Apr; 10(2):154-62. PubMed ID: 20382616
[TBL] [Abstract][Full Text] [Related]
3. Tissue and flow myocardial performance index measurements taken during dobutamine stress echocardiography for early diagnosis of late anthracycline cardiotoxicity.
Yildirim A; Tunaoğlu FS; Pinarli FG; Ilhan M; Oğuz A; Karadeniz C; Olguntürk R; Oğuz D; Kula S
Pediatr Cardiol; 2010 Jan; 31(1):96-105. PubMed ID: 19937012
[TBL] [Abstract][Full Text] [Related]
4. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines.
Lanzarini L; Bossi G; Laudisa ML; Klersy C; Aricò M
Am Heart J; 2000 Aug; 140(2):315-23. PubMed ID: 10925349
[TBL] [Abstract][Full Text] [Related]
5. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography.
Lenk MK; Zeybek C; Okutan V; Ozcan O; Gökçay E
Turk J Pediatr; 1998; 40(3):373-83. PubMed ID: 9763901
[TBL] [Abstract][Full Text] [Related]
6. The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography.
Elbl L; Hrstkova H; Chaloupka V; Novotny J; Michalek J
Neoplasma; 2003; 50(3):191-7. PubMed ID: 12937852
[TBL] [Abstract][Full Text] [Related]
7. Stress echocardiography: abnormal tissue Doppler imaging in the absence of cardiac allograft vasculopathy in heart transplant recipients.
Nguyen T; Ahmadie R; Fang T; Lytwyn M; Francis A; Barac I; Hussain F; Zieroth S; Jassal DS
Echocardiography; 2009 Feb; 26(2):182-8. PubMed ID: 19054033
[TBL] [Abstract][Full Text] [Related]
8. Dynamic Myocardial Response to Exercise in Childhood Cancer Survivors Treated with Anthracyclines.
Cifra B; Chen CK; Fan CS; Slorach C; Manlhiot C; McCrindle BW; Dragulescu A; Redington AN; Friedberg MK; Nathan PC; Mertens L
J Am Soc Echocardiogr; 2018 Aug; 31(8):933-942. PubMed ID: 29615292
[TBL] [Abstract][Full Text] [Related]
9. Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.
Leger K; Slone T; Lemler M; Leonard D; Cochran C; Bowman WP; Bashore L; Winick N
Pediatr Blood Cancer; 2015 Jan; 62(1):123-7. PubMed ID: 25176022
[TBL] [Abstract][Full Text] [Related]
10. Repetitive dobutamine stress echocardiography for the prediction of anthracycline cardiotoxicity.
Bountioukos M; Doorduijn JK; Roelandt JR; Vourvouri EC; Bax JJ; Schinkel AF; Kertai MD; Sonneveld P; Poldermans D
Eur J Echocardiogr; 2003 Dec; 4(4):300-5. PubMed ID: 14611826
[TBL] [Abstract][Full Text] [Related]
11. Tissue Doppler and myocardial deformation imaging to detect myocardial dysfunction in pediatric cancer patients treated with high doses of anthracyclines.
Yağci-Küpeli B; Varan A; Yorgun H; Kaya B; Büyükpamukçu M
Asia Pac J Clin Oncol; 2012 Dec; 8(4):368-74. PubMed ID: 22898185
[TBL] [Abstract][Full Text] [Related]
12. Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.
Ylänen K; Eerola A; Vettenranta K; Poutanen T
Eur J Pediatr; 2016 Oct; 175(10):1379-86. PubMed ID: 27620626
[TBL] [Abstract][Full Text] [Related]
13. Assessing anthracycline-treated childhood cancer survivors with advanced stress echocardiography.
Ryerson AB; Border WL; Wasilewski-Masker K; Goodman M; Meacham L; Austin H; Mertens AC
Pediatr Blood Cancer; 2015 Mar; 62(3):502-8. PubMed ID: 25393686
[TBL] [Abstract][Full Text] [Related]
14. [Intraventricular obstructions in dobutamine stress echocardiography: determinants of their development and clinical sequelae].
Wagner S; Mohr-Kahaly S; Nixdorff U; Kuntz S; Menzel T; Kölsch B; Meinert R; Meyer J
Z Kardiol; 1997 May; 86(5):327-35. PubMed ID: 9304307
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity.
Nabati M; Janbabai G; Baghyari S; Esmaili K; Yazdani J
J Cardiovasc Pharmacol; 2017 May; 69(5):279-285. PubMed ID: 28141699
[TBL] [Abstract][Full Text] [Related]
16. Dobutamine stress echocardiography identifies anthracycline cardiotoxicity.
Cottin Y; L'huillier I; Casasnovas O; Geoffroy C; Caillot D; Zeller M; Solary E; Guy H; Wolf JE
Eur J Echocardiogr; 2000 Sep; 1(3):180-3. PubMed ID: 11916591
[TBL] [Abstract][Full Text] [Related]
17. Doppler derived coronary flow reserve during dobutamine stress echocardiography further improves detection of myocardial ischemia.
Ahmari SA; Modesto K; Bunch J; Stussy V; Dichak A; Seward J; Pellikka P; Chandrasekaran K
Eur J Echocardiogr; 2006 Mar; 7(2):134-40. PubMed ID: 15996524
[TBL] [Abstract][Full Text] [Related]
18. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer.
Hamada H; Ohkubo T; Maeda M; Ogawa S
Pediatr Int; 2006 Jun; 48(3):313-20. PubMed ID: 16732801
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effect of dexrazoxane during treatment with doxorubicin: a study using low-dose dobutamine stress echocardiography.
Paiva MG; Petrilli AS; Moisés VA; Macedo CR; Tanaka C; Campos O
Pediatr Blood Cancer; 2005 Dec; 45(7):902-8. PubMed ID: 16035077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
